drugset / Trial / NCT00002370

Study of Itraconazole in Patients With Advanced HIV Infection

NCT00002370

Completed 36 enrolled Janssen, LP
Treatment

Summary

To demonstrate a dosage regimen for intravenous itraconazole that produces a plasma concentration range comparable to that obtained after currently used oral dosages of itraconazole oral solution; and to obtain preliminary safety data in patients with advanced HIV disease.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Intravenous